Though billionaire James Dinan's York Capital Management manages regulatory assets worth over $25 billion, its latest 13F filing reveals that less than 16% of it or only $4 billion...
Keep Reading →
September 26 - Hedge Fund Analysis, Hedge Funds, News - Comments
Biotechs have had a very tough year, though the healthcare sector as a whole has managed to rebound into the green year--to-date.
Keep Reading →
August 27 - Hedge Funds, News - Comments
After surging almost non-stop to $49 per barrel from $40, WTI futures are now 2% in the red while the broader indexes are pretty much flat in pre-market trading on the first trading...
Keep Reading →
August 22 - Market Movers, News - Comments
No matter how much things have changed over the past several years, Wall Street remains a place that is dominated by men.
Keep Reading →
July 20 - Hedge Fund Analysis, Hedge Funds, News - Comments
The markets opened higher today before sliding slightly into the red as investors await June’s data on import and export prices, the Treasury's budget report, and the latest...
Keep Reading →
July 13 - Market Movers, News - Comments
The benchmark S&P 500 index has jumped six points on Monday, setting a new all-time high as last week’s strong jobs report continues to buoy market sentiment.
Keep Reading →
July 11 - Market Movers, News - Comments
Redmile Group is a San Francisco-based, healthcare-focused hedge fund founded and managed by Jeremy Green, an Oxford alum with more than 20 years of experience in wealth management...
Keep Reading →
June 3 - Hedge Fund Analysis, Hedge Funds, News - Comments
The US stock market plunged after the bell on the back of April nonfarm payrolls data, which showed that 160,000 jobs were created last month, versus 200,000 expected.
Keep Reading →
May 6 - Market Movers, News - Comments
The markets are sliding on Wednesday after a report from Automatic Data Processing, which shows a decline in the growth of private sector employment.
Keep Reading →
May 4 - Market Movers, News - Comments
It's the middle of earnings season and many investors are hungrily dissecting earnings reports and management commentary to get a better view on earnings outlooks for the future...
Keep Reading →
April 28 - Market Movers, News - Comments
It's M&A Thursday, as several major M&A deals have been announced today.
Keep Reading →
April 28 - Market Movers, News - Comments
With the S&P 500 and Dow Jones barely in the green as investors remain concerned about China's slowing economy, Big Lots, Inc.
Keep Reading →
January 12 - Market Movers, News - Comments
Mariner Investment Group is a New York-based investment advisory firm founded by William Michaelcheck in 1992.
Keep Reading →
November 13 - Hedge Fund Analysis, Hedge Funds, News - Comments
Founded in 1987, Apex Capital Management invests mainly in companies that have market caps of up to $10 billion and is currently overseeing $6.5 billion in assets under management...
Keep Reading →
October 28 - Hedge Funds, News - Comments
The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.
Keep Reading →
September 17 - News - Comments
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment.
Keep Reading →
September 10 - News - Comments
In the 21st century investor’s toolkit, there are many gauges shareholders can use to track their holdings.
Keep Reading →
August 30 - News - Comments
In the eyes of many investors, hedge funds are seen as overrated, old financial tools of a forgotten age.
Keep Reading →
August 28 - News - Comments
In today’s marketplace, there are a multitude of gauges market participants can use to analyze their holdings.
Keep Reading →
August 27 - News - Comments
In the 21st century investor’s toolkit, there are tons of metrics shareholders can use to track publicly traded companies.
Keep Reading →
August 26 - News - Comments
In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets.
Keep Reading →
August 25 - News - Comments
If you were to ask many investors, hedge funds are assumed to be useless, old investment tools of a period lost to current times.
Keep Reading →
August 23 - News - Comments
There's been plenty of buzz lately about the continuing saga of the possible buyout of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) by Amgen, Inc. (NASDAQ:AMGN).
Keep Reading →
August 23 - News - Comments
Johnson & Johnson (NYSE:JNJ) completed its acquisition of privately held Aragon Pharmaceuticals earlier this week. Plans for the deal were first announced by J&J in June.
Keep Reading →
August 23 - News - Comments
There are many types of biotech companies out there with tremendous value. Today, I will focus on the ones that target prostate cancer.
Keep Reading →
August 1 - News - Comments
Biotech is booming these days. But that's not a new story by any means. Biotech stocks as a group have done very well over the past several years.
Keep Reading →
July 24 - News - Comments
There’s a lot to notice from Johnson & Johnson (NYSE:JNJ)’s earnings -- the company announced a very solid quarter.
Keep Reading →
July 17 - News - Comments
Are investors hitting the brakes on biotech? The biotech sector's one of the most boom-or-bust areas for investors, where fortunes can be won or lost.
Keep Reading →
June 24 - News - Comments
Is Incyte Corporation (NASDAQ:INCY) a buy, sell, or hold? Investors who are in the know are taking an optimistic view.
Keep Reading →
June 3 - News - Comments
As we've learned over the past few years, getting a drug approved by the Food and Drug Administration is just half the battle in the biotech sector.
Keep Reading →
May 31 - News - Comments
The Centers for Disease Control and Prevention would put heart disease at the top of the list, since it's the leading cause of death in the nation.
Keep Reading →
May 14 - News - Comments
Where have we heard the fourth-quarter-comeback plan before? Oh yes, from Johnson's predecessor who issued 2011 revenue guidance of $350 million to $400 million, with half of ...
Keep Reading →
May 9 - News - Comments
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
May 9 - News - Comments
On Thursday, Dendreon Corporation (NASDAQ:DNDN) will release its latest quarterly results.
Keep Reading →
May 7 - News - Comments
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
April 27 - News - Comments
What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Keep Reading →
April 7 - News - Comments
The biotech sector is perhaps the most volatile and risk-prone sector in the market, but investors still love it.
Keep Reading →
March 26 - News - Comments
What doesn't Johnson & Johnson (NYSE:JNJ) produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Keep Reading →
March 13 - News - Comments
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Keep Reading →
March 11 - News - Comments
As I commented last week, cancer statistics are both staggering and disappointing.
Keep Reading →
March 5 - News - Comments
Normally we have a nice blend of health-care events to take notice of each week.
Keep Reading →
February 24 - News - Comments
Earnings season is now starting to wind down, with most companies already having reported their quarterly results.
Keep Reading →
February 22 - News - Comments
Johnson & Johnson (NYSE:JNJ) may offer well-known personal-care products such as Listerine and Neutrogena, but it also boasts an impressive portfolio of market-leading therapeutic...
Keep Reading →
February 20 - News - Comments
